Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Current clinical applications of in vivo gene therapy with AAVs
Hereditary diseases are caused by mutations in genes, and more than 7,000 rare diseases
affect over 30 million Americans. For more than 30 years, hundreds of researchers have …
affect over 30 million Americans. For more than 30 years, hundreds of researchers have …
Viral vectors in gene therapy: where do we stand in 2023?
K Lundstrom - Viruses, 2023 - mdpi.com
Viral vectors have been used for a broad spectrum of gene therapy for both acute and
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …
Phenoty** and genoty** inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod …
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age
population and in children. The scope of this review is to familiarise clinicians and scientists …
population and in children. The scope of this review is to familiarise clinicians and scientists …
Inherited retinal diseases: Therapeutics, clinical trials and end points—A review
Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous group of
disorders characterised by photoreceptor degeneration or dysfunction. These disorders …
disorders characterised by photoreceptor degeneration or dysfunction. These disorders …
Pharmaceutical development of AAV-based gene therapy products for the eye
GA Rodrigues, E Shalaev, TK Karami… - Pharmaceutical …, 2019 - Springer
A resurgence of interest and investment in the field of gene therapy, driven in large part by
advances in viral vector technology, has recently culminated in United States Food and Drug …
advances in viral vector technology, has recently culminated in United States Food and Drug …
[HTML][HTML] In vivo imaging of human cone photoreceptor inner segments
D Scoles, YN Sulai, CS Langlo… - … & visual science, 2014 - jov.arvojournals.org
Purpose.: An often overlooked prerequisite to cone photoreceptor gene therapy
development is residual photoreceptor structure that can be rescued. While advances in …
development is residual photoreceptor structure that can be rescued. While advances in …
[HTML][HTML] Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives
Due to improved phenoty** and genetic characterization, the field of 'incurable'and
'blinding'inherited retinal diseases (IRDs) has moved substantially forward. Decades of …
'blinding'inherited retinal diseases (IRDs) has moved substantially forward. Decades of …
Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement
Leber congenital amaurosis (LCA) associated with retinal pigment epithelium-specific
protein 65 kDa (RPE65) mutations is a severe hereditary blindness resulting from both …
protein 65 kDa (RPE65) mutations is a severe hereditary blindness resulting from both …
Gene therapy for inherited retinal diseases: progress and possibilities
Inherited retinal diseases (IRDs) comprise a heterogeneous group of genetic disorders
affecting the retina. Caused by mutations in over 300 genes, IRDs result in visual impairment …
affecting the retina. Caused by mutations in over 300 genes, IRDs result in visual impairment …
[HTML][HTML] The genetics of normal and defective color vision
J Neitz, M Neitz - Vision research, 2011 - Elsevier
The contributions of genetics research to the science of normal and defective color vision
over the previous few decades are reviewed emphasizing the developments in the 25years …
over the previous few decades are reviewed emphasizing the developments in the 25years …